Jinxin Fertility Group Limited (HKG:1951)

Market Cap	7.91B
Revenue (ttm)	2.99B
Net Income (ttm)	301.27M
Shares Out	2.76B
EPS (ttm)	0.11
PE Ratio	26.97
Forward PE	15.74
Dividend	0.06 (2.08%)
Ex-Dividend Date	Jun 27, 2024

Volume	41,496,831
Average Volume	42,109,233
Open	2.910
Previous Close	2.910
Day's Range	2.850 - 2.960
52-Week Range	2.070 - 4.640
Beta	1.40
RSI	53.61
Earnings Date	May 29, 2025

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, an...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1951
• Employees: 3,198
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1951

Financial Performance

In 2024, Jinxin Fertility Group's revenue was 2.81 billion, an increase of 0.81% compared to the previous year's 2.79 billion. Earnings were 283.10 million, a decrease of -17.88%.

Financial numbers in CNY